Notes and references
1 A. R. Lax, G. E. Templeton and W. L. Myers, Phytopathology, 1982,
74, 503.
2 (a) G. Adam, R. Zibuck and D. J. Seebach, J. Am. Chem. Soc., 1987,
109, 6176; (b) S. L. Schreiber, S. E. Kelly, J. A. Porco, T. Sammakia
and E. M. Suh, J. Am. Chem. Soc., 1988, 110, 6210; (c) D. Seebach,
G. Adam, R. Zibuck, W. Simon, M. Rouilly, W. L. Meyers,
J. F. Hinton, T. A. Privett, G. E. Templeton, D. K. Heiny, U. Gisi
and H. Binder, Liebigs Ann. Chem., 1989, 1233; (d ) N. R. Curtis,
A. B. Holmes, M. G. Looney, N. D. Pearson and G. C. Slim,
Tetrahedron Lett., 1991, 32, 537; (e) S. Takano, Y. Shimazaki,
M. Takahashi and K. J. Ogasawara, J. Chem. Soc., Chem. Commun.,
1988, 1004; ( f ) M. Matsushita, M. Yoshida, Y. Yhang, M. Miyas-
hita, H. Irie, T. Ueno and T. Tsurushima, Chem. Pharm. Bull., 1992,
40, 524; (g) A. Fürstner and K. Langemann, J. Am. Chem. Soc.,
1997, 119, 9130.
3 (a) S. V. Ley, L. R. Cox and G. Meek, Chem. Rev., 1996, 96, 423;
(b) L. R. Cox and S. V. Ley, Chem. Soc. Rev., 1998, 27, 301.
4 (a) S. V. Ley, C. J. Hollowood and S. Yamanoi, Chem. Commun.,
2002, 15, 1624; (b) S. V. Ley and G. Meek, J. Chem. Soc., Perkin.
Trans 1, 1997, 8, 1125; (c) D. Diez-Martin, N. R. Kotecha, S. V. Ley,
S. Mantegani, J. C. Manendez, H. M. Organ, A. D. White and
B. J. Banks, Tetrahedron, 1992, 37, 7899; (d ) S. V. Ley and S. Burck-
hardt, J. Chem. Soc., Perkin Trans. 1, 2002, 874; (e) R. W. Bates,
E. Fernandez-Megia, S. V. Ley, K. Rück-Braun and D. M. G.
Tilbrook, J. Chem. Soc., Perkin Trans. 1, 1999, 1917.
5 (a) S. V. Ley and G. Meek, Chem. Commun., 1996, 317; (b) S. V.
Ley and L. R. Cox, Chem. Commun., 1996, 657; (c) S. V. Ley,
L. R. Cox, G. Meek, K. H. Metten, C. Piqué and J. M. Worrall,
J. Chem. Soc., Perkin Trans. 1, 1997, 3299; (d ) S. V. Ley, S. Burck-
hardt, L. R. Cox and G. Meek, J. Chem. Soc., Perkin Trans. 1, 1997,
3327; (e) S. V. Ley and L. R. Cox, Chem. Commun., 1998,
227; ( f ) S. V. Ley, L. R. Cox and J. M. Worrall, J. Chem. Soc.,
Perkin Trans. 1, 1998, 3349; (g) S. V. Ley, L. R. Cox, B. Middleton
and J. M. Worrall, Tetrahedron, 1999, 55, 3515; (h) S. V. Ley and
E. A. Wright, J. Chem. Soc., Perkin Trans. 1, 2000, 11, 1677.
6 S. V. Ley and C. J. Hollowood, Chem Commun., 2002, 2130.
7 S. V. Ley and L. R. Cox, J. Chem. Soc., Perkin Trans. 1, 1997,
3315.
Scheme 2 Synthesis (Ϫ)-Gloeosporone intermediate 1. Reagents and
conditions: (a) Li naphthalenide, THF, Ϫ78 ЊC rt, 17 h, 98%; (b) Pd/
C, H2, EtOAc, 12 h, 83%; (c) RuCl2(PPh3)3, benzene, K2CO3 (2 eq.), rt,
20 h, 78%; (d) 4-pentenoylchloride, DMAP (6 eq.), CH2Cl2, 0 ЊC rt,
3 h, 65%; (e) (Ph)3PCH3Cl, KOtBu, THF, 0 ЊC
rt, 85%; (f ) RuCl2-
8 S. V. Ley, L. R. Cox, B. Middleton and J. M. Worrall, Chem.
Commun., 1998, 1339.
9 Experimental procedure and data for 7 available free of charge from
ESI.
(᎐CHPh)[1,3-ImH2]P(Cy)3, CH2Cl2, 40 ЊC, 5 h, 99%; (g) KMnO4, Ac2O,
᎐
then, HF, MeCN, 4 h, 56%.
In conclusion, this work demonstrates the applicability of
π-allyltricarbonyliron lactone complexes for natural product
synthesis. In particular the use of the new lithium naphthal-
enide decomplexation protocol is an especially attractive route to
enantiopure 1,7-diol units.
10 H. Tomioka, K. Takai, K. Oshima and H. Nozaki, Tetrahedron
Lett., 1983, 24, 2185.
11 A. J. Pearson and M. K. O’Brien, J. Org. Chem., 1989, 54, 4663.
12 M. Scholl, T. M. Trnka, J. P. Morgan and R. H. Grubbs, Tetrahedron
Lett, 1999, 40, 2247.
13 P. Jensen and K. B. Sharpless, J. Org. Chem., 1974, 39, 2314.
Acknowledgements
We gratefully acknowledge the financial support from the
ESPRC, BP endowment and the Novartis Research Fellowship
(to S. V. L.).
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 3 2 6 3 – 3 2 6 4
3264